NanoViricides, Inc.NNVCNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank40
3Y CAGR-2.6%
5Y CAGR-1.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-2.6%/yr
vs +0.8%/yr prior
5Y CAGR
-1.1%/yr
Consistent
Acceleration
-3.4pp
Decelerating
Percentile
P40
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.26M | -13.9% |
| 2025 | $9.59M | +12.6% |
| 2024 | $8.52M | -4.8% |
| 2023 | $8.94M | +10.2% |
| 2022 | $8.11M | -7.2% |
| 2021 | $8.74M | +9.3% |
| 2020 | $8.00M | -7.7% |
| 2019 | $8.66M | -7.1% |
| 2018 | $9.33M | -2.9% |
| 2017 | $9.60M | - |